Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015)

Collegium Pharmaceutical's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $11.3 million for Q1 2015.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $11.3 million in Q1 2015; TTM through Mar 2015 was $11.3 million, a N/A change from a year earlier, with the FY2014 full-year figure at $12.8 million, down 74.11% from the prior year.
• Preferred Stock Liabilities slipped to $11.3 million in Q1 2015 per COLL's latest filing, from $12.8 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $12.8 million in Q4 2014 and bottomed at $11.3 million in Q1 2015.